Celldex Therapeutics (CLDX) 4.21 -0.18
CELLDEX THERAPEUTICS, Inc.
(CLDX) 4.21 -0.18
(CLDX) 4.21 -0.18
| Last Trade: | 4.20 | Day Range: | 4.12 - 4.37 |
| Trade Time: | 04:05PM | 52wk Range: | 2.05 - 5.66 |
| Prev. Close: | 4.38 | Market Cap: | 246.69M |
| Open: | 4.34 | Div Yield: | 0 |
| Volume: | 1428896 | PE: | -40 |
| EPS: | -1.09 |
The Latest On CLDX
Social Media Outlook for Thursday May 24 (HNZ, PAY, RIMM, NTAP) 5/24/12 12:20pm
Celldex Therapeutics Added to Nasdaq Biotechnology Index 5/15/12 9:30am
Notable Put Options Activity in Celldex Therapeutics 3/6/12 2:28pm
Notable Put Options Activity in Celldex Therapeutics 2/27/12 2:04pm
Celldex Prices Public Offering of Common Stock at $3.85/Share 2/24/12 10:00am
Trade CLDX
NOW!
NOW!
Partner Headlines
Press Releases
Celldex Therapeutics Added to Nasdaq Biotechnology Index 5/15/12 Business Wire
Semi-Annual Changes to the NASDAQ Biotechnology Index 5/14/12 GlobeNewswire
Celldex Reports First Quarter 2012 Financial Results 5/3/12 Business Wire
Mentor Capital Cancer Immunotherapy Index Gains 47% During First Quarter 4/17/12 Business Wire
Celldex Announces Exercise of Over-Allotment Option 3/14/12 Business Wire
Celldex Reports Fourth Quarter and Fiscal 2011 Financial Results 3/7/12 Business Wire
Celldex Therapeutics to Host Corporate 2011 Year-End and 2012 Objectives Update Call 2/29/12 Business Wire
Celldex Therapeutics to Present at the Citi 2012 Global Health Care Conference 2/24/12 Business Wire
Celldex Prices Public Offering of Common Stock 2/24/12 Business Wire
From Benzinga's Newsdesk
- 5:10 PM Tivo Guiding 1M New Subs in Next 12 Months
- 5:10 PM Rudolph Tech Guides Q2 EPS $0.16-0.17 vs $0.17 Est
- 5:09 PM CE Franklin Halted on News
- 5:08 PM Kraft Sells 3-Year Notes at 1.625%, Record Low -Bloomberg
- 5:08 PM Benzinga's M&A Chatter for Wednesday May 30, 2012
- 5:03 PM Kraft Sells 30-Year Bonds at 5% Coupon, Record Low -Bloomberg
- 05:02 PM TICC Announces Amended Dividend Reinvestment Plan
- 05:01 PM AptarGroup Will Acquire Stelmi Group for About $207M
- 05:00 PM MSCI Inc. Announces Appointment of New Chief Financial Officer
- 4:59 PM Allegheny Tech Files Automatic Mixed Securities Shelf
- 4:59 PM NCI Building Systems Reports Q2 EPS $(0.45) vs $(0.39) Est, Sales $250.2M vs $250.20M Est
- 4:53 PM Carlyle Seeks Investments from China State Bodies -Bloomberg
- 4:52 PM Fed's Rosengren Calls for More Easing; Doesn't See Employment Improvement, Sees Inflation Below 2% with Significant Downside Risks; Expects 2.3% Economic Growth This Year
- 04:49 PM Neo Material Shareholders Approve Molycorp Acquisition
- 4:46 PM Teva Begins Trading on NYSE
Brain Trust
- Copart, Inc: Bull or Bear?
- New Contract Signing Highlights Mattersight's Coaching Analytics
- Syntroleum Says It Defends Renewable Fuels Intellectual Property Rights
- Starwood to Redeem Its 6.25% Senior Notes Due 2013
- ETF Pair Trade From New Constructs (AAPL, XLK, FDN, PXN, AMZN)
- Biostar Pharmaceuticals Provides Update Regarding Gel Capsule Safety Issues
- Endologix Announces Public Offering of 2.7 Million Shares of Common Stock
- Amerigroup Receives Upgrade to Senior Debt Rating
- Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
- Tengion Announces 1-for-10 Reverse Stock Split
- Is Facebook Secretly Cloning the iPhone 5?
- Was IBM Smart to Ban Siri?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- 5 Small-Cap Short Ideas
- Earnings Scheduled For May 29
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- James Altucher Article Sends Neonode Soaring
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Social Media Chatter on Dell Around Its Earnings Report
- Opera Would Be "Another Stupid Acquisition" for Facebook, Says Analyst
